First human doses given for new malaria pill
NCT ID NCT06854042
Summary
This is the first study to test a new oral drug called E1018 in people. Researchers will give single, increasing doses to 32 healthy adults to check for safety and see how the body absorbs and eliminates the drug. The goal is to gather initial data to see if the drug is safe enough for future testing in people with malaria.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Development, LP
RECRUITINGAustin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.